Sarah James
Stock Analyst at Cantor Fitzgerald
(1.81)
# 3,041
Out of 4,711 analysts
268
Total ratings
27.67%
Success rate
-8.77%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Reiterates: Overweight | $90 | $59.58 | +51.06% | 12 | Dec 11, 2024 | |
| ACHC Acadia Healthcare Company | Reiterates: Neutral | $52 | $37.90 | +37.20% | 13 | Dec 10, 2024 | |
| PGNY Progyny | Maintains: Overweight | $30 → $17 | $14.34 | +18.55% | 14 | Nov 14, 2024 | |
| THC Tenet Healthcare | Maintains: Overweight | $168 → $177 | $129.46 | +36.72% | 19 | Oct 30, 2024 | |
| UHS Universal Health Services | Reiterates: Neutral | $219 | $180.11 | +21.59% | 24 | Oct 25, 2024 | |
| MOH Molina Healthcare | Reiterates: Overweight | $406 | $294.73 | +37.75% | 11 | Oct 24, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $400 | $276.92 | +44.45% | 19 | Oct 23, 2024 | |
| ELV Elevance Health | Maintains: Overweight | $600 → $485 | $365.96 | +32.53% | 18 | Oct 18, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $591 → $644 | $500.13 | +28.77% | 16 | Oct 16, 2024 | |
| TBRG TruBridge | Reiterates: Overweight | $13 | $18.19 | -28.53% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $21.22 | +102.64% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $7.09 | +125.67% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $392 | $303.62 | +29.11% | 18 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $395 | $247.10 | +59.85% | 19 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $44.36 | +39.77% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $5.04 | +197.62% | 10 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $4.51 | +10.86% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $9.44 | +5.93% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $84.47 | +19.57% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $151.85 | -12.41% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $16.87 | +148.96% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $4.19 | +19.33% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $4.58 | +9.17% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $10.61 | +97.93% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $72.70 | -46.35% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $69.82 | +176.43% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.16 | - | 2 | Mar 1, 2017 |
Centene
Dec 11, 2024
Reiterates: Overweight
Price Target: $90
Current: $59.58
Upside: +51.06%
Acadia Healthcare Company
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $37.90
Upside: +37.20%
Progyny
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $14.34
Upside: +18.55%
Tenet Healthcare
Oct 30, 2024
Maintains: Overweight
Price Target: $168 → $177
Current: $129.46
Upside: +36.72%
Universal Health Services
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $180.11
Upside: +21.59%
Molina Healthcare
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $294.73
Upside: +37.75%
The Cigna Group
Oct 23, 2024
Reiterates: Overweight
Price Target: $400
Current: $276.92
Upside: +44.45%
Elevance Health
Oct 18, 2024
Maintains: Overweight
Price Target: $600 → $485
Current: $365.96
Upside: +32.53%
UnitedHealth Group
Oct 16, 2024
Maintains: Overweight
Price Target: $591 → $644
Current: $500.13
Upside: +28.77%
TruBridge
Oct 4, 2024
Reiterates: Overweight
Price Target: $13
Current: $18.19
Upside: -28.53%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $21.22
Upside: +102.64%
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $7.09
Upside: +125.67%
Oct 4, 2024
Reiterates: Overweight
Price Target: $392
Current: $303.62
Upside: +29.11%
Oct 1, 2024
Reiterates: Neutral
Price Target: $395
Current: $247.10
Upside: +59.85%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $44.36
Upside: +39.77%
Sep 20, 2024
Reiterates: Overweight
Price Target: $15
Current: $5.04
Upside: +197.62%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $4.51
Upside: +10.86%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $9.44
Upside: +5.93%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $84.47
Upside: +19.57%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $151.85
Upside: -12.41%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $16.87
Upside: +148.96%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $4.19
Upside: +19.33%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $4.58
Upside: +9.17%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $10.61
Upside: +97.93%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $72.70
Upside: -46.35%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $69.82
Upside: +176.43%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.16
Upside: -